Search This Blog

Wednesday, February 20, 2019

Bristol-Myers sees over $45B of FCF generation post-closing of Celgene deal

Expected over first three full years following close of Celgene (CELG) transaction.
https://thefly.com/landingPageNews.php?id=2866981
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)